Clinical Trial Update: Post Transplant Study

View source ↗

Summary

Amgen's post-transplant clinical trial studying secondary hyperparathyroidism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Snippet

Sponsor: Amgen | Conditions: Kidney Tansplant, Secondary Hyperparathyroidism | Status: COMPLETED